Extensive Stage Small-Cell Lung Cancer with Cystic Brain Metastases: A Report of Two Cases
Article in Cancer Management and Research (March 2024)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Efficacy and safety of anlotinib plus penpulimab as second-line treatment for small cell lung cancer: A multicenter, open-label, single-arm phase II trial
Article in Cancer Pathogenesis and Therapy (February 2024)
Penpulimab combined with anlotinib in patients with R/M HNSCC after failure of platinum-based chemotherapy: a single-arm, multicenter, phase Ⅱ study
Article in ESMO Open (December 2023)